<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43511">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01871025</url>
  </required_header>
  <id_info>
    <org_study_id>2012/4025</org_study_id>
    <nct_id>NCT01871025</nct_id>
  </id_info>
  <brief_title>Early Incentive and Mobilization During COPD Exacerbation</brief_title>
  <acronym>TIME</acronym>
  <official_title>Early Incentive and Mobilization During COPD Exacerbation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Parc de Salut Mar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Parc de Salut Mar</source>
  <oversight_info>
    <authority>Spain: Comité Ético de Investigación Clínica</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the effects of early exercise training in hospitalized patients for Chronic
      Obstructive Pulmonary Disease exacerbation (COPD). Interventions are randomized. In one
      group, early exercise training (aerobic and strength) during hospitalization for COPD
      exacerbation followed by exercise training at home until 90 days to discharge and in the
      other the intervention is usual care. In both group, usual respiratory physiotherapy
      techniques during hospitalization and adequate physical activity recommendations have been
      included. The main variable is the presence of a new COPD exacerbation according to Global
      Initiative for COPD (GOLD guidelines) with a minimum of 12 months-follow up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective randomized study in hospitalized patients for Chronic Obstructive Pulmonary
      Disease exacerbation (COPD). In one group, early exercise training (aerobic and strength)
      during hospitalization for COPD exacerbation followed by exercise training at home until 90
      days to discharge and in the other the intervention is usual care. In both group, usual
      respiratory physiotherapy techniques during hospitalization and adequate physical activity
      recommendations have been included. The main variable is the presence of a new COPD
      exacerbation according to Global Initiative for COPD (GOLD guidelines) with a minimum of 12
      months-follow up.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Acute exacerbations</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of episodes of acute exacerbations defined as a sustained worsening of the patient's symptoms from their usual stable state which is beyond normal day-to-day variations, and is acute in onset. Symptoms included: worsening breathlessness, cough, increased sputum production and change in sputum colour</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of hospitalization</measure>
    <time_frame>12 monhs</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of hospitalization due to acute exacerbations or other causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance to exercise</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Six minutes walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>COPD Assessment Test (quality of life)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>International Physical Activity Questionnaire (IPAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>12 monhs</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of days in each hospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Hospital and home exercise training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Usual care plus hospital exercise training (aerobic and strength) followed by exercise training at home until 90 days to discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Usual care in COPD</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hospital and home exercise training</intervention_name>
    <description>Hospital exercise training (aerobic and strength) followed by exercise training</description>
    <arm_group_label>Hospital and home exercise training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Usual care includes respiratory physiotherapy techniques during hospitalization and adequate physical activity recommendations, but not exercise training</description>
    <arm_group_label>Usual care</arm_group_label>
    <other_name>Usual recommendations</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hospitalized patients for COPD exacerbation

        Exclusion Criteria:

          -  Hospitalization within the previous 14 days,

          -  current participation in rehabilitation program,

          -  locomotor or neurological condition or disability limiting the ability to perform
             exercise,

          -  lung transplantation or lung volume reduction surgery foreseen within 1 month after
             discharge.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diego Rodriguez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Parc de Salut Mar</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diego Rodriguez, MD</last_name>
    <phone>+34932483056</phone>
    <email>darodriguez@parcdesalutmar.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Esther Marco, MD</last_name>
    <phone>+34699706860</phone>
    <email>emarco@parcdesalutmar.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Cruces</name>
      <address>
        <city>Baracaldo</city>
        <zip>48992</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan Galdiz, MD</last_name>
      <phone>+3494603429</phone>
      <email>juanbautista.galdiziturri@osakidetza.net</email>
    </contact>
    <investigator>
      <last_name>Juan Galdiz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Diego Rodriguez, MD</last_name>
      <phone>+34932483056</phone>
      <email>darodriguez@parcdesalutmar.cat</email>
    </contact>
    <contact_backup>
      <last_name>Esther Marco, MD</last_name>
      <phone>+34699706860</phone>
      <email>emarco@parcdesalutmar.cat</email>
    </contact_backup>
    <investigator>
      <last_name>Diego Rodriguez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Esther Marco, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Gran Canaria Dr. Negrín</name>
      <address>
        <city>Las Palmas de Gran Canaria</city>
        <zip>35017</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Lopez Fernandez, MD</last_name>
      <phone>+34928352293</phone>
      <email>dlopfer@gobiernodecanarias.org</email>
    </contact>
    <investigator>
      <last_name>Daniel López Fernandez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <zip>33006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Almudena García García, MD</last_name>
      <phone>+34985107927</phone>
      <email>almugaga@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Almudena Garcia Garcia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria del Pilar Cejudo, MD</last_name>
      <phone>+34955012214</phone>
      <email>mariap.cejudo.sspa@juntadeandalucia.es</email>
    </contact>
    <investigator>
      <last_name>Maria del Pilar Cejudo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Teodoro Montemayor, MD</last_name>
      <phone>+34630729226</phone>
      <email>teodoro.montemayor@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Teodoro Montemayor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 5, 2013</lastchanged_date>
  <firstreceived_date>June 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic obstructive pulmonary disease</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
